Selected research
Market Analysis & Forecast
Global No-Exam Life Insurance Market Analysis and Forecast 2026-2032
Market perspective
The global No-Exam Life Insurance market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for No-Exam Life Insurance is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for No-Exam Life Insurance is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for No-Exam Life Insurance is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for No-Exam Life Insurance is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of No-Exam Life Insurance include State Farm, AAA, Pacific Life, Protective, Symetra, Corebridge, Legal & General America, Transamerica and Fidelity Life, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for No-Exam Life Insurance, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of No-Exam Life Insurance, also provides the revenue of main regions and countries. Of the upcoming market potential for No-Exam Life Insurance, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the No-Exam Life Insurance revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global No-Exam Life Insurance market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for No-Exam Life Insurance revenue, projected growth trends, production technology, application and end-user industry.
No-Exam Life Insurance Segment by Company
State Farm
AAA
Pacific Life
Protective
Symetra
Corebridge
Legal & General America
Transamerica
Fidelity Life
Lincoln Financial
John Hancock
Mutual of Omaha
New York Life
Nationwide Mutual Insurance Company
No-Exam Life Insurance Segment by Type
Term Life Insurance
Permanent Life Insurance
Annuity Insurance
Savings Insurance
No-Exam Life Insurance Segment by Application
Children
Adults
Senior Citizens
No-Exam Life Insurance Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global No-Exam Life Insurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of No-Exam Life Insurance and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of No-Exam Life Insurance.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of No-Exam Life Insurance in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of No-Exam Life Insurance company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, No-Exam Life Insurance revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Term Life Insurance
- Permanent Life Insurance
- Annuity Insurance
- Savings Insurance
Applications
- Children
- Adults
- Senior Citizens
Companies covered
- State Farm
- AAA
- Pacific Life
- Protective
- Symetra
- Corebridge
- Legal & General America
- Transamerica
- Fidelity Life
- Lincoln Financial
- John Hancock
- Mutual of Omaha
- New York Life
- Nationwide Mutual Insurance Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 No-Exam Life Insurance Market by Type
- 1.2.1 Global No-Exam Life Insurance Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Term Life Insurance
- 1.2.3 Permanent Life Insurance
- 1.2.4 Annuity Insurance
- 1.2.5 Savings Insurance
- 1.3 No-Exam Life Insurance Market by Application
- 1.3.1 Global No-Exam Life Insurance Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Children
- 1.3.3 Adults
- 1.3.4 Senior Citizens
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 No-Exam Life Insurance Market Dynamics
- 2.1 No-Exam Life Insurance Industry Trends
- 2.2 No-Exam Life Insurance Industry Drivers
- 2.3 No-Exam Life Insurance Industry Opportunities and Challenges
- 2.4 No-Exam Life Insurance Industry Restraints
3 Global Growth Perspective
- 3.1 Global No-Exam Life Insurance Market Perspective (2021-2032)
- 3.2 Global No-Exam Life Insurance Growth Trends by Region
- 3.2.1 Global No-Exam Life Insurance Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global No-Exam Life Insurance Market Size by Region (2021-2026)
- 3.2.3 Global No-Exam Life Insurance Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global No-Exam Life Insurance Revenue by Players
- 4.1.1 Global No-Exam Life Insurance Revenue by Players (2021-2026)
- 4.1.2 Global No-Exam Life Insurance Revenue Market Share by Players (2021-2026)
- 4.1.3 Global No-Exam Life Insurance Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global No-Exam Life Insurance Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global No-Exam Life Insurance Key Players Headquarters & Area Served
- 4.4 Global No-Exam Life Insurance Players, Product Type & Application
- 4.5 Global No-Exam Life Insurance Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global No-Exam Life Insurance Market CR5 and HHI
- 4.6.3 2025 No-Exam Life Insurance Tier 1, Tier 2, and Tier 3
5 No-Exam Life Insurance Market Size by Type
- 5.1 Global No-Exam Life Insurance Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global No-Exam Life Insurance Revenue by Type (2021-2032)
- 5.3 Global No-Exam Life Insurance Revenue Market Share by Type (2021-2032)
6 No-Exam Life Insurance Market Size by Application
- 6.1 Global No-Exam Life Insurance Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global No-Exam Life Insurance Revenue by Application (2021-2032)
- 6.3 Global No-Exam Life Insurance Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 State Farm
- 7.1.1 State Farm Company Information
- 7.1.2 State Farm Business Overview
- 7.1.3 State Farm No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.1.4 State Farm No-Exam Life Insurance Product Portfolio
- 7.1.5 State Farm Recent Developments
- 7.2 AAA
- 7.2.1 AAA Company Information
- 7.2.2 AAA Business Overview
- 7.2.3 AAA No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.2.4 AAA No-Exam Life Insurance Product Portfolio
- 7.2.5 AAA Recent Developments
- 7.3 Pacific Life
- 7.3.1 Pacific Life Company Information
- 7.3.2 Pacific Life Business Overview
- 7.3.3 Pacific Life No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.3.4 Pacific Life No-Exam Life Insurance Product Portfolio
- 7.3.5 Pacific Life Recent Developments
- 7.4 Protective
- 7.4.1 Protective Company Information
- 7.4.2 Protective Business Overview
- 7.4.3 Protective No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.4.4 Protective No-Exam Life Insurance Product Portfolio
- 7.4.5 Protective Recent Developments
- 7.5 Symetra
- 7.5.1 Symetra Company Information
- 7.5.2 Symetra Business Overview
- 7.5.3 Symetra No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.5.4 Symetra No-Exam Life Insurance Product Portfolio
- 7.5.5 Symetra Recent Developments
- 7.6 Corebridge
- 7.6.1 Corebridge Company Information
- 7.6.2 Corebridge Business Overview
- 7.6.3 Corebridge No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.6.4 Corebridge No-Exam Life Insurance Product Portfolio
- 7.6.5 Corebridge Recent Developments
- 7.7 Legal & General America
- 7.7.1 Legal & General America Company Information
- 7.7.2 Legal & General America Business Overview
- 7.7.3 Legal & General America No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.7.4 Legal & General America No-Exam Life Insurance Product Portfolio
- 7.7.5 Legal & General America Recent Developments
- 7.8 Transamerica
- 7.8.1 Transamerica Company Information
- 7.8.2 Transamerica Business Overview
- 7.8.3 Transamerica No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.8.4 Transamerica No-Exam Life Insurance Product Portfolio
- 7.8.5 Transamerica Recent Developments
- 7.9 Fidelity Life
- 7.9.1 Fidelity Life Company Information
- 7.9.2 Fidelity Life Business Overview
- 7.9.3 Fidelity Life No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.9.4 Fidelity Life No-Exam Life Insurance Product Portfolio
- 7.9.5 Fidelity Life Recent Developments
- 7.10 Lincoln Financial
- 7.10.1 Lincoln Financial Company Information
- 7.10.2 Lincoln Financial Business Overview
- 7.10.3 Lincoln Financial No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.10.4 Lincoln Financial No-Exam Life Insurance Product Portfolio
- 7.10.5 Lincoln Financial Recent Developments
- 7.11 John Hancock
- 7.11.1 John Hancock Company Information
- 7.11.2 John Hancock Business Overview
- 7.11.3 John Hancock No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.11.4 John Hancock No-Exam Life Insurance Product Portfolio
- 7.11.5 John Hancock Recent Developments
- 7.12 Mutual of Omaha
- 7.12.1 Mutual of Omaha Company Information
- 7.12.2 Mutual of Omaha Business Overview
- 7.12.3 Mutual of Omaha No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.12.4 Mutual of Omaha No-Exam Life Insurance Product Portfolio
- 7.12.5 Mutual of Omaha Recent Developments
- 7.13 New York Life
- 7.13.1 New York Life Company Information
- 7.13.2 New York Life Business Overview
- 7.13.3 New York Life No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.13.4 New York Life No-Exam Life Insurance Product Portfolio
- 7.13.5 New York Life Recent Developments
- 7.14 Nationwide Mutual Insurance Company
- 7.14.1 Nationwide Mutual Insurance Company Company Information
- 7.14.2 Nationwide Mutual Insurance Company Business Overview
- 7.14.3 Nationwide Mutual Insurance Company No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
- 7.14.4 Nationwide Mutual Insurance Company No-Exam Life Insurance Product Portfolio
- 7.14.5 Nationwide Mutual Insurance Company Recent Developments
8 North America
- 8.1 North America No-Exam Life Insurance Revenue (2021-2032)
- 8.2 North America No-Exam Life Insurance Revenue by Type (2021-2032)
- 8.2.1 North America No-Exam Life Insurance Revenue by Type (2021-2026)
- 8.2.2 North America No-Exam Life Insurance Revenue by Type (2027-2032)
- 8.3 North America No-Exam Life Insurance Revenue Share by Type (2021-2032)
- 8.4 North America No-Exam Life Insurance Revenue by Application (2021-2032)
- 8.4.1 North America No-Exam Life Insurance Revenue by Application (2021-2026)
- 8.4.2 North America No-Exam Life Insurance Revenue by Application (2027-2032)
- 8.5 North America No-Exam Life Insurance Revenue Share by Application (2021-2032)
- 8.6 North America No-Exam Life Insurance Revenue by Country
- 8.6.1 North America No-Exam Life Insurance Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America No-Exam Life Insurance Revenue by Country (2021-2026)
- 8.6.3 North America No-Exam Life Insurance Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe No-Exam Life Insurance Revenue (2021-2032)
- 9.2 Europe No-Exam Life Insurance Revenue by Type (2021-2032)
- 9.2.1 Europe No-Exam Life Insurance Revenue by Type (2021-2026)
- 9.2.2 Europe No-Exam Life Insurance Revenue by Type (2027-2032)
- 9.3 Europe No-Exam Life Insurance Revenue Share by Type (2021-2032)
- 9.4 Europe No-Exam Life Insurance Revenue by Application (2021-2032)
- 9.4.1 Europe No-Exam Life Insurance Revenue by Application (2021-2026)
- 9.4.2 Europe No-Exam Life Insurance Revenue by Application (2027-2032)
- 9.5 Europe No-Exam Life Insurance Revenue Share by Application (2021-2032)
- 9.6 Europe No-Exam Life Insurance Revenue by Country
- 9.6.1 Europe No-Exam Life Insurance Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe No-Exam Life Insurance Revenue by Country (2021-2026)
- 9.6.3 Europe No-Exam Life Insurance Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China No-Exam Life Insurance Revenue (2021-2032)
- 10.2 China No-Exam Life Insurance Revenue by Type (2021-2032)
- 10.2.1 China No-Exam Life Insurance Revenue by Type (2021-2026)
- 10.2.2 China No-Exam Life Insurance Revenue by Type (2027-2032)
- 10.3 China No-Exam Life Insurance Revenue Share by Type (2021-2032)
- 10.4 China No-Exam Life Insurance Revenue by Application (2021-2032)
- 10.4.1 China No-Exam Life Insurance Revenue by Application (2021-2026)
- 10.4.2 China No-Exam Life Insurance Revenue by Application (2027-2032)
- 10.5 China No-Exam Life Insurance Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia No-Exam Life Insurance Revenue (2021-2032)
- 11.2 Asia No-Exam Life Insurance Revenue by Type (2021-2032)
- 11.2.1 Asia No-Exam Life Insurance Revenue by Type (2021-2026)
- 11.2.2 Asia No-Exam Life Insurance Revenue by Type (2027-2032)
- 11.3 Asia No-Exam Life Insurance Revenue Share by Type (2021-2032)
- 11.4 Asia No-Exam Life Insurance Revenue by Application (2021-2032)
- 11.4.1 Asia No-Exam Life Insurance Revenue by Application (2021-2026)
- 11.4.2 Asia No-Exam Life Insurance Revenue by Application (2027-2032)
- 11.5 Asia No-Exam Life Insurance Revenue Share by Application (2021-2032)
- 11.6 Asia No-Exam Life Insurance Revenue by Country
- 11.6.1 Asia No-Exam Life Insurance Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia No-Exam Life Insurance Revenue by Country (2021-2026)
- 11.6.3 Asia No-Exam Life Insurance Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA No-Exam Life Insurance Revenue (2021-2032)
- 12.2 SAMEA No-Exam Life Insurance Revenue by Type (2021-2032)
- 12.2.1 SAMEA No-Exam Life Insurance Revenue by Type (2021-2026)
- 12.2.2 SAMEA No-Exam Life Insurance Revenue by Type (2027-2032)
- 12.3 SAMEA No-Exam Life Insurance Revenue Share by Type (2021-2032)
- 12.4 SAMEA No-Exam Life Insurance Revenue by Application (2021-2032)
- 12.4.1 SAMEA No-Exam Life Insurance Revenue by Application (2021-2026)
- 12.4.2 SAMEA No-Exam Life Insurance Revenue by Application (2027-2032)
- 12.5 SAMEA No-Exam Life Insurance Revenue Share by Application (2021-2032)
- 12.6 SAMEA No-Exam Life Insurance Revenue by Country
- 12.6.1 SAMEA No-Exam Life Insurance Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA No-Exam Life Insurance Revenue by Country (2021-2026)
- 12.6.3 SAMEA No-Exam Life Insurance Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst